BIOMAT Database Logo BIOMAT Database Logo

[RNA modification/editing and regulatory gene expression]. 2009

Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
sakura@chembio.t.u-tokyo.ac.jp

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D008780 Methyltransferases A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1. Methyltransferase
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012315 RNA Caps Nucleic acid structures found on the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA CAP ANALOGS), which lack the positive charge, inhibit the initiation of protein synthesis. RNA Cap,5' Capped RNA,5' mRNA Cap Structure,Cap, RNA,Caps, RNA,RNA, 5' Capped
D012323 RNA Processing, Post-Transcriptional Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. Post-Transcriptional RNA Modification,RNA Processing,Post-Transcriptional RNA Processing,Posttranscriptional RNA Processing,RNA Processing, Post Transcriptional,RNA Processing, Posttranscriptional,Modification, Post-Transcriptional RNA,Modifications, Post-Transcriptional RNA,Post Transcriptional RNA Modification,Post Transcriptional RNA Processing,Post-Transcriptional RNA Modifications,Processing, Posttranscriptional RNA,Processing, RNA,RNA Modification, Post-Transcriptional,RNA Modifications, Post-Transcriptional
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D017393 RNA Editing A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE, KINETOPLASTIDA). RNA, Messenger, Editing,Editing, RNA,Editings, RNA,RNA Editings

Related Publications

Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
A-to-I RNA editing: a new regulatory mechanism of global gene expression.
January 2007, Blood cells, molecules & diseases,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
Messenger RNA editing and modification.
December 1989, Current opinion in cell biology,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
ADAR regulates RNA editing, transcript stability, and gene expression.
November 2013, Cell reports,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
m1A RNA Modification in Gene Expression Regulation.
May 2022, Genes,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
RNA editing in regulating gene expression in the brain.
August 2008, Biochimica et biophysica acta,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.
June 2025, Molecular therapy : the journal of the American Society of Gene Therapy,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
RNA-guided gene editing.
March 2013, Nature methods,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
Transglycosylation: a mechanism for RNA modification (and editing?).
June 2005, Bioorganic chemistry,
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
January 2018, Methods in molecular biology (Clifton, N.J.),
Masayuki Sakurai, and Takanori Yano, and Shumpei Okada, and Yuki Takeuchi, and Tsutomu Suzuki
Genetic architecture of RNA editing, splicing and gene expression in schizophrenia.
February 2025, Human molecular genetics,
Copied contents to your clipboard!